Planning

Royal Surrey NHS Foundation Trust - Cancer and Surgical Innovation Centre - Private Patient Unit

  • Royal Surrey NHS Foundation Trust

F01: Prior information notice (prior information only)

Notice identifier: 2022/S 000-014593

Procurement identifier (OCID): ocds-h6vhtk-033fa7

Published 25 May 2022, 9:39am



Section one: Contracting authority

one.1) Name and addresses

Royal Surrey NHS Foundation Trust

Egerton Road

GUILDFORD

GU2 7XX

Contact

Katie Watson

Email

rsch.procurement@nhs.net

Telephone

+44 1483571122

Country

United Kingdom

NUTS code

UKJ - South East (England)

Internet address(es)

Main address

https://www.royalsurrey.nhs.uk/

Buyer's address

https://in-tendhost.co.uk/hplrsh/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://in-tendhost.co.uk/hplrsh/

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

National or federal Agency/Office

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Royal Surrey NHS Foundation Trust - Cancer and Surgical Innovation Centre - Private Patient Unit

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

Royal Surrey NHS Foundation Trust are looking for a commercial partner to work with us to secure the future of our specialist, high acuity surgical offering to private patients in our new Cancer and Surgical Innovation Centre.

Further details can be found below.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 85100000 - Health services

two.2.3) Place of performance

NUTS codes
  • UKJ - South East (England)

two.2.4) Description of the procurement

1. Overview of the Trust

The Royal Surrey is an award-winning organisation and we are proud to be unique in the NHS as we provide three integrated types of care in our organisation.

• Firstly, we provide acute secondary services - "normal" hospital services dedicated to the health needs of the local population of about 400,000 people across South Surrey.

• Secondly, we took over the adult community services in Guildford & Waverley in 2018, making us an integrated Trust and giving us a step-change in our ability to wrap services around patients outside of the walls of our main hospital site.

• Finally, we are a major tertiary cancer centre offering a range of services for patients across the South East of England for all but the most rare tumour groups. Currently about 50% of all activity that takes place in the Trust is concerned with the diagnosis, treatment and after-care of patients with, or suspected to have, cancer.

2. Our plans for a new Cancer and Surgical Innovation Centre

Royal Surrey is planning to build a state-of-the-art ambulatory and robotic facility to deliver world-class surgery and perioperative care. This new facility will be a powerhouse for innovation and technology, including an institute for training and education for the next generation of surgical specialists.

The new centre aims to achieve:

• Integration of surgical care to enable diagnostic and multidisciplinary support to be delivered efficiently in the Hospital.

• Ambulatory facilities that allow a larger number of procedures to be undertaken in a day case setting. This will be achieved through the creation of an ambulatory surgical centre and short-stay facility together with redesign of pre-assessment facilities.

• Improvements to the integrated emergency surgical service (CEPOD).

• Extension of the Robotic service to include additional theatres and robots to meet the demand of an increasing number of both cancer and benign conditions who would benefit from this technology

3. This new Cancer and Surgical Innovation Centre will offer patients across the SE of England access to state of the art facilities for their surgical treatment. As above, the majority of those patients will be having procedures for cancer work and a significant number of these will have access to robotic surgery.

Our goal is to deliver the new facility by the end of March 2024.

4. What we are seeking

• We are looking for a commercial partner to work with us to secure the future of our specialist, high acuity surgical offering to private patients.

• We are open to innovative forms of commercial and operational partnering arrangement but at this time we are considering the following:

o The successful partner will fund the capital for a separate floor of the new build and the equipment within it which would act as a discreet private patient unit (PPU)

o The partner would then run all aspects of the service delivered within that PPU, linking any additional services required by the Trust (e.g. provision of ITU) seamlessly for the patient

o This would generate an income stream for the Trust that must not be less than it currently receives for this private work

o Working together, it is anticipated that any partner would grow the size of the service (noting that RSFT does not have any marketing resource for its private offering currently) and that this additional upside between partners will be also be shared

• RSFT has a track record of highly successful arrangements with existing commercial partners for a number of services - any prospective bidder must be clear what is in scope and what is out of scope and how they will work with our other private patient partners

To express an interest, and register for our Enagementment Event (details TBC), please email Katie Watson at rsch.procurement@nhs.net by Friday 10th June 2022.

two.3) Estimated date of publication of contract notice

1 September 2022


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No